Drug intelligence / Profile preview

acetaminophen + salicylamide + caffeine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

A multi-ingredient, over-the-counter analgesic and antipyretic combination used for the temporary relief of mild to moderate pain (such as headache, muscle aches, dental pain, and fever). It contains three pharmacologically active small molecules: acetaminophen (analgesic and antipyretic), salicylamide (NSAID with analgesic and anti-inflammatory properties), and caffeine (a central nervous system stimulant that enhances the analgesic effect and absorption of acetaminophen and salicylamide). The combination offers broad-spectrum relief by addressing different aspects of pain and is formulated to achieve a synergistic effect, providing greater efficacy than the individual components alone[3][4][5][7][9].

Brand names
EXAPRINSaletoCrane Safety XS Pain ReliefGreen Guard Pain and Ache ReliefMedi First Pain ReliefMedi First Plus Pain ZapperAramark Pain FreeUnishield Pain Zapper
Other names
acetaminophen/aspirin/caffeine/salicylamideACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINEASPIRIN/CAFFEINE/ACETAMINOPHEN/SALICYLAMIDEPAIN FREECAFFEINE/ACETAMINOPHEN/ASPIRIN/SALICYLAMIDE
02

Targets

ADORA2A (Adenosine A₂A Receptor)ADORA3 (Adenosine A3 receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA2B (Adenosine A2B receptor)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on acetaminophen + salicylamide + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + salicylamide + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call